SPY767.25−0.53%QQQ737.68−0.92%BTC/USD83,894.74−0.65%DIA515.15−0.45%GLD378.69−3.74%TLT78.43−1.12%
Benzinga

Mesoblast Ltd (MESO) Stock Price, Quote, News & History

MESONASDAQ
Trade with Public
Trade with Public
$14.52
-0.60-4%
Last update: Sep 28, 12:55 PM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Mesoblast (MESO) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$14.39
Close
-
Volume / Avg.
145.71K / 233.03K
Day Range
$14.31 - $14.58
52 Wk Range
13.05 - 21.50
Market Cap
$1.88B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
3.49%
Days to Cover
19.38

Recent Mesoblast Limited News

Flowers Foods Posts Downbeat Q2 Results, Joins OSI Systems, Aveanna Healthcare And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

US stock futures rise, Dow up 150 points. Flowers Foods (NYSE:FLO) plunges on poor earnings & lowered forecast. Other stocks also down in pre-market.
Avi Kapoor

Mesoblast Targets $10 Billion Market With Regenerative Back Pain Treatment

Mesoblast finished patient dosing in its Phase 3 trial for a cellular back pain treatment, targeting a market worth over $10 billion.
Vandana Singh

H World Group Posts Upbeat Q2 Results, Joins Almonty Industries, Diana Shipping And Other Big Stocks Moving Higher On Monday

H World Group (HTHT) beats earnings and raises sales guidance, shares jump 8.1%. Other big gainers include ANGX, ARGX, and MESO.
Avi Kapoor

Swarmer Posts Downbeat Q2 Results, Joins TSS, ARS Pharmaceuticals, Globant And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures mixed, Dow down 0.1%. Swarmer Inc (NASDAQ: SWMR) shares drop 7% after reporting worse-than-expected financial results.
Avi Kapoor

PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday

US stocks close higher, Dow Jones up 100 points, PayPal shares rise on $53 billion acquisition proposal, other big gains from Aehr Test, Electrovaya, Robo.ai, Falcon's Beyond, Veradermics, Lucid Group, Kopin, MINISO, Mesoblast, Nexstar, Lionsgate, Karman.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-
Investing Cash Flow (TTM)
-1.02M
Financing Cash Flow (TTM)
-15.33M
Free Cash Flow (TTM)
-44.73M
Capital Expenditure (TTM)
-898.00K
Net Change in Cash (TTM)
-60.18M

Analyst Trends and Forecast

1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.04B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
16.27
PB Ratio (TTM)
3.45
Earnings Yield % (TTM)
-2.94%
Earnings Yield % (FWD)
-2.07%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.38

Company Debt

Total Debt
$119.24M
LT Debt
$108.64M
LT Debt Issuance (TTM)
$121.35M
LT Debt Repayment (TTM)
-$127.29M
Total Cash
$47.39M
Debt to Equity
0.22
Issuance of Debt (TTM)
-$5.94M
Repayment of Debt (TTM)
-$127.29M

Key Statistics

Open
$14.39
Close
-
Volume / Avg.
145.71K / 233.03K
Day Range
$14.31 - $14.58
52 Wk Range
13.05 - 21.50
Market Cap
$1.88B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
3.49%
Days to Cover
19.38

About

Sector
Health Care
Industry
Biotechnology
Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approve...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Mesoblast (MESO) stock?

A

You can purchase shares of Mesoblast (NASDAQ:MESO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Mesoblast (MESO) competitors?

Q

What is the forecast, or price target, for Mesoblast (MESO) stock?

A

Mesoblast has a consensus price target of $25.50.

Q

What is the current price for Mesoblast (MESO)?

A

The stock price for Mesoblast (NASDAQ: MESO) is $14.515 last updated September 28, 2026 at 12:55 PM EDT.

Q

Does Mesoblast (MESO) pay a dividend?

A

There are no upcoming dividends for Mesoblast.

Q

When is Mesoblast (NASDAQ:MESO) reporting earnings?

A

Mesoblast does not have any upcoming earnings scheduled.

Q

Is Mesoblast (MESO) going to split?

A

There is no upcoming split for Mesoblast.

Q

What sector and industry does Mesoblast (MESO) operate in?

A

Mesoblast is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved